home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

CAPA: Definition, Plan and Program

 
  June 18, 2018  
     
 
CfPA-The Center for Professional Advancement, Online Live
August 22, 2018 at 11:00 a.m.–12:30 p.m. (ET)


Who Should Attend?
This training is intended for professionals in the Pharmaceutical, Medical Device, Cosmetic and other related life science industries. It will be especially valuable for the following:

  • Quality Control Personnel & Management 
  • Manufacturing Personnel & Management 
  • Senior Management
  • Regulatory Affairs Personnel & Management 
  • Quality Assurance Personnel & Management 
  • Supplier Quality Personnel & Management

Course Description
This 90-minute accredited course will include discussions addressing proper CAPA system maintenance, root cause analysis, documentation of the Corrective and Preventative Actions and developing a robust CAPA plan. It will give tips on how to develop CAPAs pertaining to longer term projects and ensure they stay on track.
 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   Danielle DeLucy, MS, Independent Consultant to the Biologics and Pharmaceutical Industries


Danielle DeLucy, MS, is currently an Independent Consultant to the Biologics and Pharmaceutical Industries specializing in the areas of Quality Assurance and Quality Systems. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she has held positions in the Quality management arena while increasing her responsibility. She has helped to lead many Regulatory Health Inspections and was instrumental in the coaching process of her peers prior to any inspection. Currently, Danielle assists companies who are faced with warning letters and consent decrees establish more robust quality systems so that the company can succeed.

 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: jmorbit@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.